Samuel Menghistu active positions
| Companies | Position | Start | End |
|---|---|---|---|
Bloomwell Group GmbH
 Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020. | Director/Board Member | 2019-12-31 | - |
| Founder | 2019-12-31 | - |
Career history of Samuel Menghistu
Statistics
International
| Germany | 2 |
Operational
| Director/Board Member | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Bloomwell Group GmbH
Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020. | Health Technology |
- Stock Market
- Insiders
- Samuel Menghistu
- Experience
